Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study-Reference-Cited by-同舟云学术

Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study

Published:2023-05 Issue: Volume:182 Page:109571
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Das Indra J.,Yadav Poonam,Andersen Aaron D.,Chen Zhe Jay,Huang Long,Langer Mark P.,Lee Choonik,Li Lin,Popple Richard A.,Rice Roger K.,Schiff Peter B.,Zhu Timothy C.,Abazeed Mohamed E.

Funder

National Institutes of Health

University of Pennsylvania

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference66 articles.

1. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology;Timmerman;Semin Radiat Oncol,2008

2. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial;Palma;J Clin Oncol,2020

3. Local control after stereotactic body radiation therapy for liver tumors;Ohri;Int J Radiat Oncol Biol Phys,2021

4. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma;Hong;Int J Radiat Oncol Biol Phys,2014

5. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer;Kadoya;Int J Radiat Oncol Biol Phys,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment planning and delivery practice of lung SBRT: Results of the 2022 ESTRO physics survey;Radiotherapy and Oncology;2024-07

2. Stereotactic Body Radiotherapy as a Curative Treatment for De Novo Mucosal Carcinoma of the Head and Neck: A Feasible Alternative Option for Fragile Patients with Small Lesion: A Systematic Review;Cancers;2024-05-31